BofA downgraded Nutrien (NTR) to Neutral from Buy with an unchanged $67 price target The firm sees a “more balanced risk-reward” for the stock given that the fertilizer price rally is likely running out of steam amid “persistent concerns” regarding the ag cycle, the analyst tells investors in a research note. Nutrien’s valuation of about 7-times expected 2026 EBITDA also looks “fair” following the stock’s 38% year-to-date gain, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTR:
- Closing Bell Movers: Rumble jumps 11% on Perplexity partnership
- Largest borrow rate increases among liquid names
- U.S. to investigate crop suppliers for antitrust violations, Bloomberg says
- Nutrien price target lowered to $60 from $61 at Jefferies
- Nutrien to Divest Stake in Profertil for $600 Million